Abcam PLC | Balance Sheet

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
39,545.00
58,333.00
60,992.00
71,475.00
93,164.00
96,200
Total Accounts Receivable
16,053.00
14,527.00
17,345.00
25,849.00
26,108.00
31,300
Inventories
15,330.00
14,753.00
19,803.00
19,675.00
21,761.00
29,600
Other Current Assets
1,387.00
3,316.00
2,382.00
2,655.00
5,755.00
7,000
Total Current Assets
72,315.00
90,929.00
100,522.00
119,654.00
146,788.00
164,100
Net Property, Plant & Equipment
7,501.00
8,502.00
12,451.00
17,623.00
22,321.00
25,100
Total Investments and Advances
29.00
180.00
224.00
-
193.00
900
Intangible Assets
115,061.00
103,725.00
130,015.00
182,670.00
189,099.00
220,500
Other Assets
-
1,000.00
1,636.00
-
-
-
Total Assets
199,917.00
206,594.00
249,946.00
329,562.00
361,696.00
414,800
Accounts Payable
4,812.00
3,737.00
4,669.00
4,241.00
6,872.00
Income Tax Payable
2,325.00
2,782.00
4,813.00
1,958.00
3,348.00
Other Current Liabilities
10,844.00
10,313.00
11,576.00
27,094.00
24,506.00
Total Current Liabilities
17,981.00
16,832.00
21,058.00
33,293.00
34,726.00
Deferred Taxes
6,273.00
6,583.00
9,681.00
13,323.00
16,457.00
Other Liabilities
375.00
21.00
5.00
12,141.00
99.00
Total Liabilities
29,640.00
25,694.00
35,842.00
68,372.00
54,577.00
Common Equity (Total)
170,277.00
180,900.00
214,104.00
261,190.00
307,119.00
Total Shareholders' Equity
170,277.00
180,900.00
214,104.00
261,190.00
307,119.00
Total Equity
170,277.00
180,900.00
214,104.00
261,190.00
307,119.00
Liabilities & Shareholders' Equity
199,917.00
206,594.00
249,946.00
329,562.00
361,696.00

About Abcam

View Profile
Address
330 Cambridge Science Park
Cambridge East Anglia CB4 0FL
United Kingdom
Employees -
Website http://abcam.com
Updated 07/08/2019
Abcam Plc distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. The company was founded by Adam Robert David Cleevely, Anthony Kouzarides and Jonathan Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.